Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.

Thrombosis research - 1 Oct 2014

Kjellberg Ulla, van Rooijen Marianne, Bremme Katarina, Hellgren Margareta

Abstract excerpt

BACKGROUND: The risk of venous thromboembolism is enhanced in pregnant carriers of the Factor V Leiden mutation. The primary aim of the study was to compare prothrombin fragments 1+2, soluble fibrin and D-dimer levels in pregnant Factor V Leiden mutation carriers with those in non-carriers. Secondary aims were to evaluate whether these biomarkers could predict placenta-mediated complications or venous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Cesarean Section
Share to Fibrin Fibrinogen Degradation Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Postpartum Period

Share to Pregnancy Complications, Hematologic

Share to Protein Precursors

Share to Prothrombin

Share to Venous Thromboembolism

Source

Identifiers

PMID: 25135795
DOI: 10.1016/j.thromres.2014.07.037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.PMID 25135795Read ↗

Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.Semantic proximity Read ↗

Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.Semantic proximity Read ↗

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.Semantic proximity Read ↗

Placental vascular pathology and increased thrombin generation as mechanisms of disease in obstetrical syndromesSemantic proximity Read ↗

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study.Semantic proximity Read ↗

Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction.Semantic proximity Read ↗

Von Willebrand disease (VWD) and pregnancy: a comprehensive overviewSemantic proximity Read ↗

Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.Semantic proximity Read ↗

Changes in Fibrinogen and D‐Dimer During Complicated and Uncomplicated PregnancySemantic proximity Read ↗

Genetic risk assessment of pregnancy-associated venous thromboembolism: dual utility of maternal peripheral blood in NIPT and VTE evaluation.Semantic proximity Read ↗

Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.